Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies

Clinical and Vaccine Immunology

Volumn 20, Issue 2, 2013, Pages 197-204

  Villard, O ^a   Breit, L ^a   Cimon, B ^b   Franck, J ^c   Fricker Hidalgo, H ^d   Godineau, N ^e   Houze, S ^f   Paris, L ^g   Pelloux, H ^d   Villena, I ^h   Candolfi, E ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c TIMONE HOSPITAL   (France)

^d UNIV GRENOBLE ALPES   (France)

^e Laboratoire de Parasitologie Mycologie   (France)

^f BICHAT HOSPITAL   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN;

ARTICLE; CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY; COMPETITIVE LUMINEX IMMUNOASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED FLUORESCENCE ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SERODIAGNOSIS; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANTIBODIES, PROTOZOAN; ANTIBODY AFFINITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREGNANCY; REAGENT KITS, DIAGNOSTIC; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84874845883     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00356-12     Document Type: Article

References (28)

1. Montoya JG, Remington JS. 2008. Management of Toxoplasma gondii infection during pregnancy. Clin. Infect. Dis. 47:554-566.
2. Couvreur J. 1962. Congenital toxoplasmosis. Vie Med. 43:1839-1842.
3. Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, Decoster A, Villena I, Jenum PA, Hayde M, Naessens A. 1999. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am. J. Obstet. Gynecol. 181:843-847.
4. Villard O, Jung-Etienne J, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E, Le Reseau du Centre National de Référence de la Toxoplasmose. 2011. Sérodiagnostic de la toxoplasmose en 2010: conduite à tenir et interpretation en fonction des profils sérologiques obtenus par les méthodes de dépisage. Feuillets Biol. 52:1-7.
5. Pratlong F. 2002. Toxoplasmosis and pregnancy: current trends in serological follow-up. Gynecol. Obstet. Fertil. 30:237-243.
6. Hedman K, Lappalainen M, Seppaia I, Makela O. 1989. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J. Infect. Dis. 159:736-740.
7. Roberts A, Hedman K, Luyasu V, Zufferey J, Bessieres MH, Blatz RM, Candolfi E, Decoster A, Enders G, Gross U, Guy E, Hayde M, Ho-Yen D, Johnson J, Lecolier B, Naessens A, Pelloux H, Thulliez P, Petersen E. 2001. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur. J. Clin. Microbiol. Infect. Dis. 20:467-474.
8. Curdt I, Praast G, Sickinger E, Schultess J, Herold I, Braun HB, Bernhardt S, Maine GT, Smith DD, Hsu S, Christ HM, Pucci D, Hausmann M, Herzogenrath J. 2009. Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays. J. Clin. Microbiol. 47:603-613.
9. Flori P, Bellete B, Crampe C, Maudry A, Patural H, Chauleur C, Hafid J, Raberin H, Tran Manh Sung R. 2008. A technique for dating toxoplasmosis in pregnancy and comparison with the Vidas anti-toxoplasma IgG avidity test. Clin. Microbiol. Infect. 14:242-249.
10. Fricker-Hidalgo H, Saddoux C, Suchel-Jambon AS, Romand S, Fous-sadier A, Pelloux H, Thulliez P. 2006. New Vidas assay for Toxoplasmaspecific IgG avidity: evaluation on 603 sera. Diagn. Microbiol. Infect. Dis. 56:167-172.
11. Martin C, Morin O. 2006. Comparison of liaison automatised diagnostic system (DiaSorin) and Platelia microplate (BioRad) for the serological diagnosis of toxoplasmosis evaluation of the toxoplasma specific immunoglobulin G avidity. Rev. Francophone Lab. 386:71-76.
12. Petersen E, Borobio MV, Guy E, Liesenfeld O, Meroni V, Naessens A, Spranzi E, Thulliez P. 2005. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondiispecific immunoglobulin G (IgG) and IgM and the IgG avidity index. J. Clin. Microbiol. 43:1570-1574.
13. Villard O, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E. 2012. Evaluation of the usefulness of six commercial agglutination assays for serologic diagnosis of toxoplasmosis. Diagn. Microbiol. Infect. Dis. 73:231-235.
14. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E. 1996. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 15:799-805.
15. Gay-Andrieu F, Fricker-Hidalgo H, Sickinger E, Espern A, Brenier-Pinchart MP, Braun HB, Pelloux H. 2009. Comparative evaluation of the ARCHITECT Toxo IgG, IgM, and IgG Avidity assays for anti-Toxoplasma antibodies detection in pregnant women sera. Diagn. Microbiol. Infect. Dis. 65:279-287.
16. Alvarado-Esquivel C, Sethi S, Janitschke K, Hahn H, Liesenfeld O. 2002. Comparison of two commercially available avidity tests for toxoplasmaspecific IgG antibodies. Arch. Med. Res. 33:520-523.
17. Bobic B, Klun I, Vujanic M, Nikolic A, Ivovic V, Zivkovic T, Djurkovic-Djakovic O. 2009. Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings. J. Med. Microbiol. 58:358-364.
18. Lachaud L, Calas O, Picot MC, Albaba S, Bourgeois N, Pratlong F. 2009. Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination. Diagn. Microbiol. Infect. Dis. 64: 267-274.
19. Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, Wallon M, King L, Goulet V. 2010. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 15:19600.
20. Candolfi E, Pastor R, Huber R, Filisetti D, Villard O. 2007. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn. Microbiol. Infect. Dis. 58:83-88.
21. Press C, Montoya JG, Remington JS. 2005. Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults. J. Clin. Microbiol. 43:3481-3483.
22. Buffolano W, Lappalainen M, Hedman L, Ciccimarra F, Del Pezzo M, Rescaldani R, Gargano N, Hedman K. 2004. Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 23:825-830.
23. Lefevre-Pettazzoni M, Bissery A, Wallon M, Cozon G, Peyron F, Rabilloud M. 2007. Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women. Clin. Vaccine Immunol. 14:239-243.
24. Sensini A, Pascoli S, Marchetti D, Castronari R, Marangi M, Sbaraglia G, Cimmino C, Favero A, Castelletto M, Mottola A. 1996. IgG avidity in the serodiagnosis of acute Toxoplasma gondii infection: a multicenter study. Clin. Microbiol. Infect. 2:25-29.
25. Ancelle T, Yera H, Talabani H, Lebuisson A, Thuillez P, Dupouy-Camet J. 2009. How can the cost of screening for toxoplasmosis during pregnancy be reduced? Rev. Epidemiol. Sante Publique 57:411-417.
26. Cozon GJ, Ferrandiz J, Nebhi H, Wallon M, Peyron F. 1998. Estimation of the avidity of immunoglobulin G for routine diagnosis of latent Toxoplasma gondii infection in pregnant women. Eur. J. Clin. Microbiol. Infect. Dis. 17:32-36.
27. Stillwaggon E, Carrier CS, Sautter M, McLeod R. 2011. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl. Trop. Dis. 5:e1333. doi:10.1371/journal.pntd.0001333.
28. Pfrepper KI, Enders G, Gohl M, Krczal D, Hlobil H, Wassenberg D, Soutschek E. 2005. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin. Diagn. Lab. Immunol. 12:977-982.